Cardiovascular Surgical and Interventional Procedures to 2022

Global Dynamics of Surgical and Interventional Cardiovascular Procedures, 2015-2022
· 355 pages · 175 Exhibits · Report #C500 · Published August 2016

Price: $1,450 (print or PDF; add $200 for both).
Site/Global License also available.

Request excerpts

Order online or send your order form.

This report covers surgical and interventional therapeutic procedures commonly used in the management of acute and chronic conditions affecting myocardium and vascular system. The latter include ischemic heart disease (and its life threatening manifestations like AMI, cardiogenic shock, etc.); heart failure; structural heart disorders (valvular abnormalities and congenital heart defects); peripheral artery disease (and limb and life threatening critical limb ischemia); aortic disorders (AAA, TAA and aortic dissections); acute and chronic venous conditions (such as deep venous thrombosis, pulmonary embolism and chronic venous insufficiency); neurovascular pathologies associated with high risk of hemorrhagic and ischemic stroke (such as cerebral aneurysms and AVMs, and high-grade carotid/intracranial stenosis); and cardiac rhythm disorders (requiring correction with implantable pulse generators/IPG or arrhythmia ablation).

The report offers current assessment and projected procedural dynamics (2015 to 2022) for primary market geographies (e.g., United States, Largest Western European Countries, and Major Asian States) as well as the rest-of-the-world.

The cited procedural assessments and forecasts are based on the systematic analysis of a multiplicity of sources including (but not limited to):

  • Latest and historic company SEC filings, corporate presentations, and interviews with product management and marketing staffers;
  • Data released by authoritative international institutions (such as OECD and WHO), and national healthcare authorities;
  • Statistical updates and clinical practice guidelines from professional medical associations (like AHA, ACC, European Society of Cardiology, etc.);
  • Specialty presentations at major professional conferences (e.g., TCT, AHA Scientific Sessions, EuroPCR, etc.);
  • Publications in major medical journals (JAMA, NEJM) and specialty magazines (CathLab digest, Endovascular Today, etc.);
  • Findings from relevant clinical trials;
  • Feedback from leading clinicians (end-users) in the field on device/procedure utilization trends and preferences; and
  • Policy papers by major medical insurance carriers on uses of particular surgical and interventional tools and techniques, their medical necessity and reimbursement.

Surgical and Interventional Procedures Covered:

  • Coronary artery bypass graft (CABG) surgery
  • Coronary angioplasty and stenting
  • Lower extremity arterial bypass surgery
  • Percutaneous transluminal angioplasty (PTA) with and without bare metal and drug-eluting stenting
  • Peripheral drug-coated balloon angioplasty
  • Peripheral atherectomy
  • Surgical and endovascular aortic aneurysm repair
  • Vena cava filter placement
  • Endovenous ablation
  • Mechanical venous thrombectomy
  • Venous angioplasty and stenting
  • Carotid endarterectomy
  • Carotid artery stenting
  • Cerebral thrombectomy
  • Cerebral aneurysm and AVM surgical clipping
  • Cerebral aneurysm and AVM coiling & flow diversion
  • Left Atrial Appendage closure
  • Heart valve repair and replacement surgery
  • Transcatheter valve repair and replacement
  • Congenital heart defect repair
  • Percutaneous and surgical placement of temporary and permanent mechanical cardiac support devices
  • Pacemaker implantation
  • Implantable cardioverter defibrillator placement
  • Cardiac resynchronization therapy device placement
  • Standard SVT & VT ablation
  • Transcatheter AFib ablation

Table of Contents

Executive Summary

SECTION 1: Common Acute and Chronic Cardiovascular Conditions Targeted by Surgical and Transcatheter Intervenions
1.1 Circulatory Myocardial Disorders
1.1.1 Ischemic Heart Disease and Heart Failure
1.1.2 Acute Myocardial Infarction
1.1.3 Cardiogenic Shock
1.1.4 Heart Failure
1.1.4.1 Classifications of Heart Failure
1.2 Peripheral Artery Disorders
1.2.1 Peripheral Artery Disease and Critical Limb Ischemia
1.2.2 Aortic Aneurysm
1.3 Peripheral Venous Disorders
1.3.1 Deep Venous Thrombosis and Pulmonary Embolism
1.3.2 Chronic Venous Insufficiency
1.4 Cerebrovascular Disorders
1.4.1 Acute Stroke
1.4.1.1 Ischemic Stroke
1.4.1.2 Hemorrhagic Stroke
1.5 Structural Heart Disorders
1.5.1 Congenital Heart Defects
1.5.2 Heart Valve Disorders
1.6 Cardiac Rhythm Disorders
1.6.1 Bradycardia
1.6.2 Supraventricular Tachycardia
1.6.2.1 Atrial Fibrillation
1.6.3 Ventricular Tachycardia

SECTION 2: Current and Projected Volumes of Therapeutic Interventional and Surgical Cardiovascular Procedures
2.1 Ischemic Heart Disease Treatment
2.1.1 Coronary Artery Bypass Graft Surgery
2.1.1.1 Less Invasive Variations of CABG
2.1.1.2 Patient Indications and Outcomes
2.1.1.3 CABG Utilization Trends and Procedure Volumes
2.1.2 Percutaneous Coronary Interventions
2.1.2.1 Percutaneous Transluminal Coronary Angioplasty & Stenting
2.1.2.1.1 PTCA/Stenting Procedure Volumes
2.2 Mechanical Circulatory Support in Acute and Chronic Heart Failure Management
2.2.1 MCS (VAD) Placement Procedure Volumes
2.3 Peripheral Artery Revascularization
2.3.1 Bypass Graft Surgery for Revascularization of the Lower Extremity Arterial Occlusions
2.3.1.1 Femoro-Popliteal Bypass Surgery
2.3.1.2 Aortoiliofemoral Bypass Graft Surgery
2.3.1.3 Distal Tibial-Peroneal Vacsular Reconstruction
2.3.1.4 Lower Extremity Surgical Bypass Grafting Procedure Volumes
2.3.2 Peripheral Transcatheter Interventions
2.3.2.1 Percutaneous Transluminal Angioplasty (PTA)
2.3.2.2 Lower Extremity Stenting
2.3.2.3 Lower Extremity Arterial Angioplasty and Stenting Procedure Volumes
2.3.2.4 Drug-Coated Balloon Angioplasty
2.3.2.5 DCB Angioplasty Procedure Volumes
2.3.2.6 Mechanical Atherectomy
2.3.2.7 Atherectomy Procedure Volumes
2.4 Aortic Aneurysm Repair
2.4.1 Surgical Repair of Aortic Aneurysms
2.4.2 Abdominal Aortic Aneurysm Repair with Endovascular Stent-Grafts
2.4.2.1 Limitations of Endovascular AAA Repair
2.4.3 Endovascular Repair of TAA
2.4.4 Aortic Aneurysm Repair Procedure Volumes
2.5 Prophylaxis of Pulmonary Embolism and Treatment of Chronic Venous Insufficiency and Deep Venous Thrombosis
2.5.1 Inferior Vena Cava (IVC) Filter Placement
2.5.1.1 IVC Filter Placement Procedure Volumes
2.5.2 Endovenous Ablation for CVI
2.5.2.1 2Endovenous Ablation Procedure Volumes
2.5.3 Mechanical and Hybrid Thrombectomy for DVT
2.5.3.1 Accumulated Clinical Experience
2.5.3.2 Venous Thrombectomy Procedure Volumes
2.5.4 Venous Stenting
2.5.4.1 Accumulated Clinical Experience
2.5.1.2 Venous Stenting Procedure Volumes
2.6 Acute Stroke Prophylaxis and Treatment
2.6.1 High-Grade Carotid Artery Stenosis Management
2.6.1.1 Carotid Endarterectomy
2.6.1.2 Carotid Artery Stenting
2.6.1.2.1 CREST Trial Results
2.6.1.3 Carotid Endarterectomy and Stenting Procedure Volumes
2.6.2 Left Atrial Appendage Closure
2.6.2.1 Surgical Closure of Left Atrial Appendage
2.6.2.2 Endovascular Closure of Left Atrial Appendage
2.6.2.2.1 Clinical Experience with Endovascular LAA Closure Systems
2.6.2.2.2 Left Atrial Appendage Endovascular Closure Procedure Volumes
2.6.3 Cerebral Thrombectomy
2.6.3.1 Clinical Experience with Cerebral Thrombectomy Systems
2.6.3.2 Cerebral Thrombectomy Procedure Volumes
2.6.4 Cerebral Aneurysm and AVM Repair in Prophylaxis of Hemorrhagic Stroke
2.6.4.1 Treatment Options
2.6.4.1.1 Surgical Repair of Cerebral Aneurysms and AVMs
2.6.4.1.2 Endovascular Embolization of Cerebral Aneurysms and AVMs
2.6.4.2 Cerebral Aneurysm & AVM Embolization Procedure Volumes
2.7 Management of Structural Heart Disorders
2.7.1 Congenital Heart Defects Repair
2.7.1.1 Projected Procedure Volumes
2.7.2 Heart Valve Repair and Replacement
2.7.2.1 Heart Valve Surgery
2.7.2.2 Percutaneous Heart Valve Repair and Replacement
2.7.2.3 Projected Procedure Volumes
2.8 Cardiac Rhythm Management
2.8.1 Implantable Pulse Generator Systems
2.8.1.1 Cardiac Pacing Systems
2.8.1.2 Implantable Cardioverter Defibrillators
2.8.1.3 Cardiac Resynchronization Therapy Systems
2.8.1.4 Pacemaker, ICD and CRT Device Placement Procedure Volumes
2.8.2 Arrhythmia Ablation Therapy
2.8.2.1 Ablation of Atrial Fibrillation
2.8.2.1.1 Surgical AFib Ablation Techniques
2.8.2.1.2 Catheter AFib Ablation Techniques
2.8.2.2 Cardiac Arrhythmia Ablation Procedure Volumes

SECTION 3: Country Healthcare Profiles
3.1 United States
3.2 Major Western European States
3.2.1 Overview of European Healthcare
3.2.1.1 Healthcare Spending and Reforms
3.2.1.2 Healthcare Facilities and Manpower
3.2.1.3 Reimbursement
3.2.1.4 Impact of the European Union
3.2.2 National Healthcare Profiles
3.2.2.1 France
3.2.2.2 Germany
3.2.2.3 Italy
3.2.2.4 Spain
3.2.2.5 United Kingdom
3.3 Major Asian States
3.3.1 China
3.3.2 India
3.3.3 Japan

List of Exhibits

Exhibit ES-1: Projected Global Dynamics of Interventional and Surgical Cardiovascular Procedures, 2015-2022 (#000)
Exhibit ES-2: Projected Geographic Dynamics and Distribution of Interventional and Surgical Cardiovascular Procedures, 2015-2022 (#000)
Exhibit ES-3: Projected Dynamics of Interventional and Surgical Cardiovascular Procedures, United States 2015-2022 (#000)
Exhibit ES-4: Projected Dynamics of Interventional and Surgical Cardiovascular Procedures, Largest Western European States, 2015-2022 (#000)
Exhibit ES-5: Projected Dynamics of Interventional and Surgical Cardiovascular Procedures, Major Asia-Pacific States, 2015-2022 (#000)
Exhibit ES-6: Projected Dynamics of Interventional and Surgical Cardiovascular Procedures, Rest-of-the-World, 2015-2022 (#000)

Exhibit 1-1: Ischemic Heart Disease, Facts and Figures
Exhibit 1-2: Acute Myocardial Infarction Facts and Figures
Exhibit 1-3: Cardiogenic Shock Facts and Figures
Exhibit 1-4: Heart Failure Facts and Figures
Exhibit 1-5: Peripheral Artery Disease: Facts And Figures (2015)
Exhibit 1-6: Aortic Aneurysm: Facts And Figures (2015)
Exhibit 1-7 Deep Venous Thrombosis: Facts & Figures (2015)
Exhibit 1-8: Chronic Venous Insufficiency: Facts And Figures (2010)
Exhibit 1-9: Clinical Features and Characteristics of Ischemic Stroke (2015)
Exhibit 1-10: Clinical Features and Characteristics of Hemorrhagic Stroke (2015)
Exhibit 1-11: Clinical Characteristics of the Most Prevalent Congenital Heart Defects
Exhibit 1-12: Congenital Heart Defects, Facts and Figures (2015)
Exhibit 1-13: Heart Valve Disorders Facts and Figures (2015)
Exhibit 1-14: Estimated and Projected Incidence and Prevalence of Common Cardiac Rhythm Disorders (2015)

Exhibit 2-1: Projected Global Dynamics of Interventional and Surgical Cardiovascular Procedures, 2015-2022 (#000)
Exhibit 2-2: Projected Geographic Dynamics and Distribution of Interventional and Surgical Cardiovascular Procedures, 2015-2022 (#000)
Exhibit 2-3: Projected Dynamics of Interventional and Surgical Cardiovascular Procedures, United States 2015-2022 (#000)
Exhibit 2-4: Projected Dynamics of Interventional and Surgical Cardiovascular Procedures, Largest Western European States, 2015-2022 (#000)
Exhibit 2-5: Projected Dynamics of Interventional and Surgical Cardiovascular Procedures, Major Asia-Pacific States, 2015-2022 (#000)
Exhibit 2-6: Projected Dynamics of Interventional and Surgical Cardiovascular Procedures, Rest-of-the-World, 2015-2022 (#000)
Exhibit 2-7: CABG-PCI: Projected Dynamics of Coronary Revascularization Procedures, United States, 2015-2022 (#000)
Exhibit 2-8: CABG-PCI: Projected Dynamics of Coronary Revascularization Procedures, Major Western Europe, 2015-2022 (#000)
Exhibit 2-9: CABG-PCI: Projected Dynamics of Coronary Revascularization Procedures, Major Asia-Pacific, 2015-2022 (#000)
Exhibit 2-10: CABG-PCI: Projected Dynamics of Coronary Revascularization Procedures, Rest-of-the-World, 2015-2022 (#000)
Exhibit 2-11: CABG-PCI: Projected Dynamics of Coronary Revascularization Procedures, World Total, 2015-2022 (#000)
Exhibit 2-12: U.S., PCI and CABG, 2016 & 2022
Exhibit 2-13: Western Europe, PCI and CABG, 2016 & 2022
Exhibit 2-14: Asia-Pacific, PCI and CABG, 2016 & 2022
Exhibit 2-15: Rest of World, PCI and CABG, 2016 & 2022
Exhibit 2-16: MCS: Projected Dynamics of Mechanical Cardiac Support (MCS) Procedures, United States, 2015-2022
Exhibit 2-17: MCS: Projected Dynamics of Mechanical Cardiac Support (VAD) Placement Procedures, Western Europe, 2015-2022
Exhibit 2-18: MCS: Projected Dynamics of Mechanical Cardiac Support (VAD) Placement Procedures, Asia-Pacific, 2015-2022
Exhibit 2-19: MCS: Projected Dynamics of Mechanical Cardiac Support (VAD) Placement Procedures, Rest-of-the-World, 2015-2022
Exhibit 2-20: MCS: Projected Dynamics of Mechanical Cardiac Support (VAD) Placement Procedures, World Total, 2015-2022
Exhibit 2-21: U.S., Temporary and Permanent Mechanical Support Procedures, 2016 & 2022
Exhibit 2-22: Western Europe, Temporary and Permanent Mechanical Support Procedures, 2016 & 2022
Exhibit 2-23: Asia-Pacific, Temporary and Permanent Mechanical Support Procedures, 2016 & 2022
Exhibit 2-24: Rest of World, Temporary and Permanent Mechanical Support Procedures, 2016 & 2022
Exhibit 2-25: PVD-Bypass: Projected Dynamics of Peripheral Artery Bypass Procedures, United States, 2015-2022 (#000)
Exhibit 2-26: PVD-Bypass: Projected Dynamics of Peripheral Artery Bypass Procedures, Major Western Europe, 2015-2022 (#000)
Exhibit 2-27: PVD-Bypass: Projected Dynamics of Peripheral Artery Bypass Procedures, Major Asia-Pacific, 2015-2022 (#000)
Exhibit 2-28: PVD-Bypass: Projected Dynamics of Peripheral Artery Bypass Procedures, Rest-of-the-World, 2015-2022 (#000)
Exhibit 2-29: PVD-Bypass: Projected Dynamics of Peripheral Artery Bypass Procedures, World Total, 2015-2022 (#000)
Exhibit 2-30: Lower Extremity Bypass, By Region, 2015-2022
Exhibit 2-31: LE PTA: Projected Dynamics of the Lower Extremity Angioplasty-Stenting Procedures, United States, 2015-2022 (#000)
Exhibit 2-32: LE PTA: Projected Dynamics of the Lower Extremity Angioplasty-Stenting Procedures, Major Western Europe, 2015-2022 (#000)
Exhibit 2-33: LE-PTA: Projected Dynamics of Peripheral Angioplasty-Stenting Procedures, Major Asia-Pacific, 2015-2022 (#000)
Exhibit 2-34: LE-PTA: Projected Dynamics of Peripheral Angioplasty-Stenting Procedures, Rest-of-the-World, 2015-2022 (#000)
Exhibit 2-35: LE-PTA: Projected Dynamics of Peripheral Angioplasty-Stenting Procedures, World Total, 2015-2022 (#000)
Exhibit 2-36: Lower Extremity Angioplasty and Drug-Eluting and Bare Metal Stent Procedures, By Region 2016
Exhibit 2-37: Lower Extremity Angioplasty and Drug-Eluting and Bare Metal Stent Procedures, By Region 2022
Exhibit 2-38: LE-DCB: Projected Dynamics of Peripheral Drug-Coated Balloon Angioplasty Procedures, United States, 2015-2022 (#000)
Exhibit 2-39: LE DCB: Projected Dynamics of Peripheral Drug-Coated Balloon Angioplasty Procedures, Major Western Europe, 2015-2022 (#000)
Exhibit 2-40: LE-DCB: Projected Dynamics of Peripheral Drug-Coated Balloon Angioplasty Procedures, Major Asia-Pacific, 2015-2022 (#000)
Exhibit 2-41: LE-DCB: Projected Dynamics of Peripheral Drug-Coated Balloon Angioplasty Procedures, Rest-of-the-World, 2015-2022 (#000)
Exhibit 2-42: LE-DCB: Projected Dynamics of Peripheral Drug-Coated Balloon Angioplasty Procedures, World Total, 2015-2022 (#000)
Exhibit 2-43: Lower Extremity Angioplasty, With and Without Drug-Coated Balloon, By Region 2016
Exhibit 2-44: Lower Extremity Angioplasty, With and Without Drug-Coated Balloon, By Region 2022
Exhibit 2-45: PVD-Atherectomy: Projected Dynamics of the Lower Extremity Atherectomy Procedures, United States, 2015-2022 (#000)
Exhibit 2-46: PVD-Atherectomy: Projected Dynamics of the Lower Extremity Atherectomy Procedures, Major Western Europe, 2015-2022 (#000)
Exhibit 2-47: PVD-Atherectomy: Projected Dynamics of the Lower Extremity Atherectomy Procedures, Major Asia-Pacific, 2015-2022 (#000)
Exhibit 2-48: PVD-Atherectomy: Projected Dynamics of the Lower Extremity Atherectomy Procedures, Rest-of-the-World, 2015-2022 (#000)
Exhibit 2-49: PVD-Atherectomy: Projected Dynamics of the Lower Extremity Atherectomy Procedures, World Total, 2015-2022 (#000)
Exhibit 2-50: Lower Extremity Atherectomy, By Region, 2016 & 2022
Exhibit 2-51: Thrombectomy-DVT: Projected Dynamics of DVT Targeting Thrombectomy Procedures, United States, 2015-2022 (#000)
Exhibit 2-52: Thrombectomy-DVT: Projected Dynamics of DVT Targeting Thrombectomy Procedures, Major Western Europe, 2015-2022 (#000)
Exhibit 2-53: Thrombectomy-DVT: Projected Dynamics of DVT Targeting Thrombectomy Procedures, Major Asian-Pacific States, 2015-2022 (#000)
Exhibit 2-54: Thrombectomy-DVT: Projected Dynamics of DVT Targeting Thrombectomy Procedures, Rest-of-the-World, 2015-2022 (#000)
Exhibit 2-55: Thrombectomy-DVT: Projected Dynamics of DVT Targeting Thrombectomy Procedures, World Total, 2015-2022 (#000)
Exhibit 2-56: DVT Thrombectomy, By Region, 2016 & 2022
Exhibit 2-57: AAA-TAA: Projected Dynamics of Aortic Aneurysm Repair Procedures, United States, 2015-2022 (#000)
Exhibit 2-58: AAA-TAA: Projected Dynamics of Aortic Aneurysm Repair Procedures, Largest Western European States, 2015-2022 (#000)
Exhibit 2-59: AAA-TAA: Projected Dynamics of Aortic Aneurysm Repair Procedures, Major Asian-Pacific States, 2015-2022 (#000)
Exhibit 2-60: AAA-TAA: Projected Dynamics of Aortic Aneurysm Repair Procedures, Rest-of-the-World, 2015-2022 (#000)
Exhibit 2-61: AAA-TAA: Projected Dynamics of Aortic Aneurysm Repair Procedures, World Total, 2015-2022 (#000)
Exhibit 2-62: U.S. Surgical and Endovascular AAA/TAA Repair, 2016 & 2022
Exhibit 2-63: Western Europe, Surgical and Endovascular AAA/TAA, 2016 & 2022
Exhibit 2-64: Asia-Pacific, Surgical and Endovascular AAA/TAA, 2016 & 2022
Exhibit 2-65: Rest of World, Surgical and Endovascular AAA/TAA, 2016 & 2022
Exhibit 2-66: VCF-PE: Projected Dynamics of Inferior Vena Cava Filter Placement Procedures, United States, 2015-2022 (#000)
Exhibit 2-67: VCF-PE: Projected Dynamics of Inferior Vena Cava Filter Placement Procedures, Major Western Europe, 2015-2022 (#000)
Exhibit 2-68: VCF-PE: Projected Dynamics of Inferior Vena Cava Filter Placement Procedures, Major Asian-Pacific States, 2015-2022 (#000)
Exhibit 2-69: VCF-PE: Projected Dynamics of Inferior Vena Cava Filter Placement Procedures, Rest-of-the-World, 2015-2022 (#000)
Exhibit 2-70: VCF-PE: Projected Dynamics of Inferior Vena Cava Filter Placement Procedures, World Total, 2015-2022 (#000)
Exhibit 2-71: Inferior Vena Cava Filter Placements, By Region, 2016 & 2022
Exhibit 2-72: CVI-EVT: Projected Dynamics of CVI-Targeting Endovenous Ablation Procedures, United States, 2015-2022 (#000)
Exhibit 2-73: CVI-EVT: Projected Dynamics of CVI-Targeting Endovenous Ablation Procedures, Major Western Europe, 2015-2022 (#000)
Exhibit 2-74: CVI-EVT: Projected Dynamics of CVI-Targeting Endovenous Ablation Procedures, Major Asian-Pacific States, 2015-2022 (#000)
Exhibit 2-75: CVI-EVT: Projected Dynamics of CVI-Targeting Endovenous Ablation Procedures, Rest-of-the-World, 2015-2022 (#000)
Exhibit 2-76: CVI-EVT: Projected Dynamics of CVI-Targeting Endovenous Ablation Procedures, World Total, 2015-2022 (#000)
Exhibit 2-77: Chronic Venous Insufficiency Endovenous Ablation, By Region, 2016 & 2022
Exhibit 2-78: Projected Dynamics of DVT Targeting Thrombectomy Procedures, United States, 2015-2022 (#000)
Exhibit 2-79: Thrombectomy-DVT: Projected Dynamics of DVT Targeting Thrombectomy Procedures, Major Western Europe, 2015-2022 (#000)
Exhibit 2-80: Thrombectomy-DVT: Projected Dynamics of DVT Targeting Thrombectomy Procedures, Major Asian-Pacific States, 2015-2022 (#000)
Exhibit 2-81: Thrombectomy-DVT: Projected Dynamics of DVT Targeting Thrombectomy Procedures, Rest-of-the-World, 2015-2022 (#000)
Exhibit 2-82: Thrombectomy-DVT: Projected Dynamics of DVT Targeting Thrombectomy Procedures, World Total, 2015-2022 (#000)
Exhibit 2-83: Deep Vein Thrombosis Thrombectomy, By Region, 2016 & 2022
Exhibit 2-84: Venous Stenting: Projected Dynamics of Venous Stenting Procedures, United States, 2015-2022 (#000)
Exhibit 2-85: Venous Stenting: Projected Dynamics of Venous Stenting Procedures, Major Western Europe, 2015-2022 (#000)
Exhibit 2-86: Venous Stenting: Projected Dynamics of Venous Stenting Procedures, Major Asian-Pacific States, 2015-2022 (#000)
Exhibit 2-87: Venous Stenting: Projected Dynamics of Venous Stenting Procedures, Rest-of-the-World, 2015-2022 (#000)
Exhibit 2-88: Venous Stenting: Projected Dynamics of Venous Stenting Procedures, World Total, 2015-2022 (#000)
Exhibit 2-89: Venous Stenting Procedures, By Region, 2016 & 2022
Exhibit 2-90: Projected Dynamics of Venous Stenting Procedures, United States, 2015-2022 (#000)
Exhibit 2-91: CAS-CEA: Projected Dynamics of Carotid Artery Revascularization Procedures, United States, 2015-2022 (#000)
Exhibit 2-92: CAS-CEA: Projected Dynamics of Carotid Artery Revascularization Procedures, Major Western Europe, 2015-2022 (#000)
Exhibit 2-93: CAS-CEA: Projected Dynamics of Carotid Artery Revascularization Procedures, Major Asian-Pacific States, 2015-2022 (#000)
Exhibit 2-94: CAS-CEA: Projected Dynamics of Carotid Artery Revascularization Procedures, Rest-of-the-World, 2015-2022 (#000)
Exhibit 2-95: CAS-CEA: Projected Dynamics of Carotid Artery Revascularization Procedures, World Total, 2015-2022 (#000)
Exhibit 2-96: U.S. Carotid Artery Procedures, 2016 & 2022
Exhibit 2-97: Western Europe Carotid Artery Procedures, 2016 & 2022
Exhibit 2-98: Asia-Pacific Carotid Artery Procedures, 2016 & 2022
Exhibit 2-99: Rest of World Carotid Artery Procedures, 2016 & 2022
Exhibit 2-100: Projected Dynamics of Left Atrial Appendix Closure Procedures, United States, 2015-2022 (#000)
Exhibit 2-101: Worldwide Left Atrial Appendage Closure, By Region, 2016 & 2022
Exhibit 2-102: Cerebral Thrombectomy: Projected Dynamics of Cerebral Thrombectomy Procedures, United States, 2015-2022 (#000)
Exhibit 2-103: Cerebral Thrombectomy: Projected Dynamics of Cerebral Thrombectomy Procedures, Major Western Europe, 2015-2022 (#000)
Exhibit 2-104: Cerebral Thrombectomy: Projected Dynamics of Cerebral Thrombectomy Procedures, Major Asian-Pacific States, 2015-2022 (#000)
Exhibit 2-105: Cerebral Thrombectomy: Projected Dynamics of Cerebral Thrombectomy Procedures, Rest-of-the-World, 2015-2022 (#000)
Exhibit 2-106: Cerebral Thrombectomy: Projected Dynamics of Cerebral Thrombectomy Procedures, World Total, 2015-2022 (#000)
Exhibit 2-107: Cerebral Thrombectomy, By Region, 2016 & 2022
Exhibit 2-108: Projected Dynamics of Cerebral Aneurysm & AVM Repair Procedures, United States, 2015-2022 (#000)
Exhibit 2-109: Projected Dynamics of Cerebral Aneurysm & AVM Repair Procedures, Largest Western States, 2015-2022 (#000)
Exhibit 2-110: Projected Dynamics of Cerebral Aneurysm & AVM Repair Procedures, Major Asia Pacific States, 2015-2022 (#000)
Exhibit 2-111: Projected Dynamics of Cerebral Aneurysm & AVM Repair Procedures, Rest of World, 2015-2022 (#000)
Exhibit 2-112: Projected Dynamics of Cerebral Aneurysm & AVM Repair Procedures, World Total, 2015-2022 (#000)
Exhibit 2-113: U.S. Cerebral Aneurysm and AVM Repairs, 2016 & 2022
Exhibit 2-114: Western Europe, Cerebral Aneurysm and AVM Repairs, 2016 & 2022
Exhibit 2-115: Asia-Pacific, Cerebral Aneurysm and AVM Repairs, 2016 & 2022
Exhibit 2-116: Rest of World, Cerebral Aneurysm and AVM Repairs, 2016 & 2022
Exhibit 2-117: Heart Defects: Projected Dynamics of Congenital Heart Defect Repair Procedures, United States, 2015-2022 (#000)
Exhibit 2-118: Heart Defects: Projected Dynamics of Congenital Heart Defect Repair Procedures, Major Western Europe, 2015-2022 (#000)
Exhibit 2-119: Heart Defects: Projected Dynamics of Congenital Heart Defect Repair Procedures, Major Asia-Pacific, 2015-2022 (#000)
Exhibit 2-120: Heart Defects: Projected Dynamics of Congenital Heart Defect Repair Procedures, Rest-of-the-World, 2015-2022 (#000)
Exhibit 2-121: Heart Defects: Projected Dynamics of Congenital Heart Defect Repair Procedures, World Total, 2015-2022 (#000)
E Exhibit 2-122: Congenital Heart Defect Repairs, By Region, 2016
Exhibit 2-123: Congenital Heart Defect Repairs, By Region, 2022
Exhibit 2-124: Valves: Projected Dynamics of Heart Valve Replacement and Repair Procedures, United States, 2015-2022
Exhibit 2-125: Projected Dynamics of Heart Valve Replacement and Repair Procedures, Major Western Europe, 2015-2022
Exhibit 2-126: Valves: Projected Dynamics of Heart Valve Replacement and Repair Procedures, Major Asia-Pacific, 2015-2022
Exhibit 2-127: Valves: Projected Dynamics of Heart Valve Replacement and Repair Procedures, Rest-of-the-World, 2015-2022
E Exhibit 2-128: Projected Dynamics of Heart Valve Replacement and Repair Procedures, World Total, 2015-2022
Exhibit 2-129: U.S. Surgical and Transcatheter Heart Valve Replacements, 2016 & 2022
Exhibit 2-130: Western Europe Surgical and Transcatheter Heart Valve Replacements, 2016 & 2022
Exhibit 2-131: Asia-Pacific Surgical and Transcatheter Heart Valve Replacements, 2016 & 2022
Exhibit 2-132: Rest of World Surgical and Transcatheter Heart Valve Replacements, 2016 & 2022
Exhibit 2-133: CRM-IPG: Projected Dynamics of Implantable Pulse Generator Placement Procedures, United States, 2015-2022 (#000)
Exhibit 2-134: CRM-IPG: Projected Dynamics of Implantable Pulse Generator Placement Procedures, Major Western Europe, 2015-2022 (#000)
Exhibit 2-135: CRM-IPG: Projected Dynamics of Implantable Pulse Generator Placement Procedures, Major Asia-Pacific, 2015-2022 (#000)
Exhibit 2-136: CRM-IPG: Projected Dynamics of Implantable Pulse Generator Placement Procedures, Rest-of-the-World, 2015-2022 (#000)
Exhibit 2-137: CRM-IPG: Projected Dynamics of Implantable Pulse Generator Placement Procedures, World Total, 2015-2022 (#000)
Exhibit 2-138: Implantable Pulse Generator Placements, By Region, 2016 & 2022
E Exhibit 2-139: AFib Ablation: Projected Dynamics of EP – AFib Ablation Procedures, United States, 2015-2022 (#000)
Exhibit 2-140: EP-AFib Ablation: Projected Dynamics of EP – AFib Ablation Procedures, Major Western Europe, 2015-2022 (#000)
Exhibit 2-141: AFib Ablation: Projected Dynamics of EP – AFib Ablation Procedures, Major Asia-Pacific, 2015-2022 (#000)
Exhibit 2-142: EP-AFib Ablation: Projected Dynamics of EP – AFib Ablation Procedures, Rest-of-the-World, 2015-2022 (#000)
Exhibit 2-143: EP-AFib Ablation: Projected Dynamics of EP – AFib Ablation Procedures, World Total, 2015-2022 (#000)
Exhibit 2-144: Atrial Fibrillation Procedures, By Region, 2016 & 2022

Exhibit 3-1: United States, Selected Healthcare/Public Health Indicators, 2015
Exhibit 3-2: France, Selected Healthcare/Public Health Indicators, 2015
Exhibit 3-4: Italy, Selected Healthcare/Public Health Indicators, 2015
Exhibit 3-5: Spain, Selected Healthcare/Public Health Indicators, 2015
Exhibit 3-6: United Kingdom, Selected Healthcare/Public Health Indicators, 2015
Exhibit 3-7: China, Selected Healthcare/Public Health Indicators, 2015
Exhibit 3-8: India, Selected Healthcare/Public Health Indicators, 2015
Exhibit 3-9: Japan, Selected Healthcare/Public Health Indicators, 2015

Methodology.
MedMarket Diligence Reports are produced through primary and secondary research. Primary research includes interviews with clinicians, industry representatives, and other stakeholders in the market for their knowledge and insights on product development, market development, clinical practice and trends associated with the evolving use of technologies. Secondary data includes SEC filings; company annual reports; regional, federal, and international datasets; brokerage other investment reports; and other independent market research is used to corroborate and support assessments and projections. Reports are written and researched by industry insiders, whose familiarity with the companies, industry dynamics and other marketplace specifics facilitate the research process and ensure high quality and thorough reports.


Global Dynamics of Surgical and Interventional Cardiovascular Procedures, 2015-2022
· 355 pages · 175 Exhibits · Report #C500 · Published August 2016

Price: $1,450 (print or PDF; add $200 for both).
Site/Global License also available.
Order online or send your order form.